{
    "clinical_study": {
        "@rank": "46871", 
        "brief_summary": {
            "textblock": "The primary objective of this study is to build a well characterized cohort of patients that\n      will be used to determine the genetic variants associated with OSA (obstructive sleep\n      apnea)and its co-morbidities."
        }, 
        "brief_title": "A Prospective Observational Cohort to Study the Genetics of Obstructive Sleep Apnea and Associated Co-Morbidities", 
        "completion_date": {
            "#text": "June 2017", 
            "@type": "Anticipated"
        }, 
        "condition": "Obstructive Sleep Apnea", 
        "condition_browse": {
            "mesh_term": [
                "Apnea", 
                "Sleep Apnea Syndromes", 
                "Sleep Apnea, Obstructive"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        We will recruit subjects who are:\n\n          -  18 years of age and older.\n\n          -  Willing and able to give informed consent\n\n        AND any of the following:\n\n          -  PSG (polysomnogram)requested by a physician based on clinical grounds\n\n          -  AHI  (Apnea-hypopnea index) \u2265 5 episodes per hour based on a prior PSG.\n\n        Exclusion Criteria:\n\n        Incapable of giving informed consent\n\n          -  Under the age of 18 Vulnerable Populations 3\n\n          -  Children, fetuses, neonates, or prisoners are not included in this research study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "care clinics"
            }
        }, 
        "enrollment": {
            "#text": "5000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 10, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01857427", 
            "org_study_id": "2012H0214"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "December 17, 2013", 
        "location": {
            "contact": {
                "email": "ulysses.magalang@osumc.edu", 
                "last_name": "Ulysses Magalang, MD", 
                "phone": "614-293-4925"
            }, 
            "facility": {
                "address": {
                    "city": "Columbus", 
                    "country": "United States", 
                    "state": "Ohio", 
                    "zip": "43221"
                }, 
                "name": "Suite 2600, Martha Morehouse Medical Pavilion"
            }, 
            "investigator": {
                "last_name": "Ulysses Magalang, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "A Prospective Observational Cohort to Study the Genetics of Obstructive Sleep Apnea and Associated Co-Morbidities", 
        "overall_official": {
            "affiliation": "Ohio State University", 
            "last_name": "Ulyesses Magalang, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The primary objective of this study is to build a well characterized cohort of patients that will be used to determine the genetic variants associated with OSA and its co-morbidities. The purpose of building the cohort is to allow the performance of genome-wide association studies with a large sample of patients that have been well-characterized using standardized procedures.", 
            "measure": "To build a cohort of patients with OSA", 
            "safety_issue": "No", 
            "time_frame": "The study procedures will take approximately 48 hours to finish since subjects will be asked to wear the equipment that records the ambulatory 24 hour blood pressure after the research visit. The research visit will last approximately 2 hours."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01857427"
        }, 
        "responsible_party": {
            "investigator_affiliation": "The Ohio State University", 
            "investigator_full_name": "Ulysses Magalang MD", 
            "investigator_title": "Professor of Internal Medicine", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": {
            "description": "This will be powered based on levels of high-sensitivity C-reactive (hsCRP) protein. The sample size for this study will be based on ANOVA analysis of hsCRP  in patients with different degrees of OSA severity (normal, mild, moderate, severe).  539 subjects will have a power of 80% to detect an effect size of 0.01 pg.mL-1 with an expected standard deviation of  0.05 pg.mL-1. The 539 subjects for this aim will be included in the patients enrolled in Aim 1, that is, these are not additional subjects to the 5000 patients that will be enrolled in Aim 1. These subjects will be enrolled consecutively and enrollment for this aim will be terminated when 539 subjects have been included.", 
            "measure": "To measure changes in inflammatory biomarkers, adipokines, and RNA molecules in OSA patients", 
            "safety_issue": "No", 
            "time_frame": "After the potential subject has agreed to participate and informed consent procedures have been initiated the subject will have blood drawn for subsequent DNA extraction."
        }, 
        "source": "Ohio State University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ulysses Magalang MD", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "December 2013"
    }
}